1-[4-(4-Benzenesulfonyl-5-oxy-furazan-3-yloxy)-5-hydroxymethyl-tetrahydro-furan-2-yl]-5-methyl-1H-pyrimidine-2,4-dione

ID: ALA3144457

Chembl Id: CHEMBL3144457

PubChem CID: 11155544

Max Phase: Preclinical

Molecular Formula: C18H18N4O9S

Molecular Weight: 466.43

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cn([C@H]2C[C@H](Oc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)[C@@H](CO)O2)c(=O)[nH]c1=O

Standard InChI:  InChI=1S/C18H18N4O9S/c1-10-8-21(18(25)19-15(10)24)14-7-12(13(9-23)29-14)30-16-17(22(26)31-20-16)32(27,28)11-5-3-2-4-6-11/h2-6,8,12-14,23H,7,9H2,1H3,(H,19,24,25)/t12-,13+,14+/m0/s1

Standard InChI Key:  YMDLSHZOALFOFD-BFHYXJOUSA-N

Associated Targets(Human)

143B (353 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hs-578T (29457 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

KBALB cell line (25 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EMT6 (738 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 466.43Molecular Weight (Monoisotopic): 466.0794AlogP: -0.97#Rotatable Bonds: 6
Polar Surface Area: 180.66Molecular Species: NEUTRALHBA: 11HBD: 2
#RO5 Violations: 1HBA (Lipinski): 13HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.96CX Basic pKa: CX LogP: -0.46CX LogD: -0.46
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.43Np Likeness Score: -0.16

References

1. Moharram S, Zhou A, Wiebe LI, Knaus EE..  (2004)  Design and synthesis of 3'- and 5'-O-(3-benzenesulfonylfuroxan-4-yl)-2'-deoxyuridines: biological evaluation as hybrid nitric oxide donor-nucleoside anticancer agents.,  47  (7): [PMID:15027876] [10.1021/jm030544m]

Source